NCT06396533View on ClinicalTrials.gov

Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE)

RecruitingOBSERVATIONAL

Enrollment

92

Participants

Timeline

Start Date

August 13, 2024

Primary Completion Date

April 23, 2027

Study Completion Date

February 23, 2029

Conditions

Urothelial CarcinomaMuscle Invasive Bladder Urothelial CarcinomaNon-Muscle Invasive Bladder Urothelial Carcinoma

Trial Locations (1)

19111

RECRUITING

Fox Chase Cancer Center, Philadelphia

Sponsors

Collaborators (1)

Janssen Pharmaceuticals

All Listed Sponsors

collaborator

Janssen Pharmaceuticals

INDUSTRY

lead

Fox Chase Cancer Center

OTHER

NCT06396533 - Increasing Pre-Surgical Identification of Muscle Invasive Tumor Evaluations Prior to Planned Cystectomy (INSITE) | Biotech Hunter | Biotech Hunter